Abstract:AbstractBackground: Biomarkers of exposure are tools for understanding the impact of tobacco use on health outcomes if confounders like demographics, use behavior, biological half-life, and other sources of exposure are accounted for in the analysis. Methods: We performed multiple regression analysis of longitudinal measures of urinary biomarkers of alkaloids, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, volatile organic compounds (VOC), and metals to examine the sample-to-sample consistency in Waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) Study including demographic characteristics and use behavior variables of persons who smoked exclusively. Regression coefficients, within- and between-person variance, and intra-class correlation coefficients (ICC) were compared with biomarker smoking/nonsmoking population mean ratios and biological half-lives. Results: Most biomarkers were similarly associated with sex, age, race/ethnicity, and product use behavior. The biomarkers with larger smoking/nonsmoking population mean ratios had greater regression coefficients related to recency of exposure. For VOC and alkaloid metabolites, longer biological half-life was associated with lower within-person variance. For each chemical class studied, there were biomarkers that demonstrated good ICCs. Conclusions: For most of the biomarkers of exposure reported in the PATH Study, for people who smoke cigarettes exclusively, associations are similar between urinary biomarkers of exposure and demographic and use behavior covariates. Biomarkers of exposure within-subject consistency is likely associated with nontobacco sources of exposure and biological half-life. Impact: Biomarkers measured in the PATH Study provide consistent sample-to-sample measures from which to investigate the association of adverse health outcomes with the characteristics of cigarettes and their use.

Supplementary Table S14 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S15 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S13 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S17 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S9 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S32 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S26 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S18 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S40 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S28 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S36 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S30 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Supplementary Table S42 from Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study

Influence of Half-life and Smoking/Nonsmoking Ratio on Biomarker Consistency Between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study.

Source Data for the Project Entitled "altered DNA Methylation Within DNMT3A, AHRR, LTA/TNF Loci Mediate the Effect of Smoking on Inflammatory Bowel Disease"

Supplementary Figure S2 from the Effects of Black Raspberry As a Whole Food–Based Approach on Biomarkers of Oxidative Stress in Buccal Cells and Urine of Smokers

Supplementary Table S2 from The Effects of Black Raspberry as a Whole Food–Based Approach on Biomarkers of Oxidative Stress in Buccal Cells and Urine of Smokers

Association of urinary biomarkers of tobacco exposure with lung cancer risk in African American and White cigarette smokers in the Southern Community Cohort Study

Urinary Biomarkers of Carcinogenic Exposure among Cigarette, Waterpipe, and Smokeless Tobacco Users and Never Users of Tobacco in the Golestan Cohort Study.

Concentrations of Cotinine and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in US Non-Daily Cigarette Smokers

Supplementary Figure 1 from A Pooled Analysis of Smoking and Colorectal Cancer: Timing of Exposure and Interactions with Environmental Factors